Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Ruan Pimenta, Feres Camargo Malulf, Poliana Romão, Giovana Vilas Boas Caetano, Karina Serafim da Silva, Vitoria Ghazarian, Gabriel A. dos Santos, Vanessa Guimarães, Iran Amorim Silva, Juliana Alves de Camargo, Saulo Recuero, Bárbara V. Lima Aguiar Melão, Alberto Azoubel Antunes, Miguel Srougi, William Nahas, Katia R. M. Leite & Sabrina T. Reis. (2024) Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression. Journal of Cancer Research and Clinical Oncology 150:2.
Crossref
Crossref
Rong Jia, Wen Xun, Guozhou Liao, Yuan Yang & Guiying Wang. (2023) Comparison of the Fatty Acid Composition and Small Molecular
Metabolites between Yanjin Blackbone Chicken and Piao Chicken
Meat. Food Science of Animal Resources 43:6, pages 975-988.
Crossref
Crossref
Bangqiang Zhu, Hu Gao, Fang Yang, Yiyang Li, Qiaoyue Yang, Yinchang Liao, Haimin Guo, Kang Xu, Zhiqiang Tang, Ning Gao, Yuebo Zhang & Jun He. (2023) Comparative Characterization of Volatile Compounds of Ningxiang Pig, Duroc and Their Crosses (Duroc × Ningxiang) by Using SPME-GC-MS. Foods 12:5, pages 1059.
Crossref
Crossref
Sabba Mehmood, Shaista Aslam, Erum Dilshad, Hammad Ismail & Amna Naheed Khan. 2023. Therapeutic Approaches in Cancer Treatment. Therapeutic Approaches in Cancer Treatment
15
47
.
Amit V Varma, Seema Jindal, Bela Sharda, Kamal Malukani, Shilpi Dosi & Pooja Kesharwani. (2022) Study of Immunohistochemical Marker Psma and Ki 67 Expression and Its Relation with Grading in Prostate Carcinoma. annals of urologic oncology, pages 1-14.
Crossref
Crossref
Na Luo, Li Liu, Xiaoya Yuan, Yuxi Jin, Guiping Zhao, Jie Wen & Huanxian Cui. (2022) A Comparison of Different Tissues Identifies the Main Precursors of Volatile Substances in Chicken Meat. Frontiers in Physiology 13.
Crossref
Crossref
Adree Khondker, Jethro CC Kwong, Christopher Tran, Emily Evans, Ishan Aditya, Lucshman Raveendran, Yingming A Chen, Amna Ali & Andrew Feifer. (2022) Incidence of dural metastases in castrate-resistant prostate cancer. Journal of Clinical Urology, pages 205141582210900.
Crossref
Crossref
Manuel Ramirez-Garrastacho, Cristina Bajo-Santos, Aija Line, Elena S. Martens-Uzunova, Jesus Martinez de la Fuente, Maria Moros, Carolina Soekmadji, Kristin Austlid Tasken & Alicia Llorente. (2021) Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research. British Journal of Cancer 126:3, pages 331-350.
Crossref
Crossref
Maria Adamaki & Vassilios Zoumpourlis. (2021) Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics. Pharmacology & Therapeutics 228, pages 107932.
Crossref
Crossref
Yuxi Jin, Huanxian Cui, Xiaoya Yuan, Lu Liu, Xiaojing Liu, Yongli Wang, Jiqiang Ding, Hai Xiang, Xinxiao Zhang, Jianfeng Liu, Hua Li, Guiping Zhao & Jie Wen. (2021) Identification of the main aroma compounds in Chinese local chicken high-quality meat. Food Chemistry 359, pages 129930.
Crossref
Crossref
Anna Kałuża, Justyna Szczykutowicz & Mirosława Ferens-Sieczkowska. (2021) Glycosylation: Rising Potential for Prostate Cancer Evaluation. Cancers 13:15, pages 3726.
Crossref
Crossref
Xiangping Lin, Lucie Lécuyer, Xinyu Liu, Mohamed N. Triba, Mélanie Deschasaux-Tanguy, Aïcha Demidem, Zhicheng Liu, Tony Palama, Adrien Rossary, Marie-Paule Vasson, Serge Hercberg, Pilar Galan, Philippe Savarin, Guowang Xu & Mathilde Touvier. (2021) Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry. Cancers 13:13, pages 3140.
Crossref
Crossref
Anna Gratacós-Mulleras, Adrià Duran, Akram Asadi Shehni, Montserrat Ferrer-Batallé, Manel Ramírez, Josep Comet, Rafael de Llorens, Radka Saldova, Esther Llop & Rosa Peracaula. (2020) Characterisation of the main PSA glycoforms in aggressive prostate cancer. Scientific Reports 10:1.
Crossref
Crossref
Cuimin Sun, Hui You, Nailong Gao, Jianguo Chang, Qingxue Gao, Yang Xie, Yao Xie & Ronald X. Xu. (2020) Design and fabrication of a microfluidic chip to detect tumor markers. RSC Advances 10:65, pages 39779-39785.
Crossref
Crossref
Anshika N. Singh & Neeti Sharma. (2020) Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Simone Badal, William Aiken, Belinda Morrison, Henkel Valentine, Sophia Bryan, Andrew Gachii & Camille Ragin. (2019) Disparities in prostate cancer incidence and mortality rates: Solvable or not?. The Prostate 80:1, pages 3-16.
Crossref
Crossref
Wendy L. Johnston, Charles N. Catton & Carol J. Swallow. (2019) Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer. BMC Urology 19:1.
Crossref
Crossref
Gennady M. Zharinov, Oleg A. Bogomolov, Natalia Yu. Neklasova, Grigory A. Raskin, Irina V. Chepurnaya, Sergey N. Bugrov & Vladimir N. Anisimov. (2019) Prognostic value of tumor growth kinetic parameters in prostate cancer patients. Oncotarget 10:49, pages 5020-5027.
Crossref
Crossref
Hui Wang, Sheng Tai, Li Zhang, Jun Zhou & Chaozhao Liang. (2019) A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor. Scientific Reports 9:1.
Crossref
Crossref
I. Ezgi Eryilmaz, Berna Aytac Vuruskan, Onur Kaygısız, Unal Egeli, Berrin Tunca, Yakup Kordan & Gulsah Cecener. (2018)
RNA‐based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of
T2E
fusion positivity and
MMP‐2
upregulation for a subsequent prostate cancer diagnosis
. The Prostate 79:2, pages 195-205.
Crossref
Crossref
Meng Zhang, Huaiqian Dou, Dandan Yang, Ming Shan, Xiulian Li, Cui Hao, Yiran Zhang, Pengjiao Zeng, Yanli He, Yong Liu, Jing Fu, Wei Wang, Minghui Hu, Hui Li, Qingwu Tian, Shuhe Lei & Lijuan Zhang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A
141
163
.
Arie Carneiro, Álan Roger Gomes Barbosa, Lucas Seiti Takemura, Paulo Priante Kayano, Natasha Kouvaleski Saviano Moran, Carolina Ko Chen, Marcelo Langer Wroclawski, Gustavo Caserta Lemos, Isabela Werneck da Cunha, Marcos Takeo Obara, Marcos Tobias-Machado, Adam G. Sowalsky & Bianca Bianco. (2018) The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature. Frontiers in Oncology 8.
Crossref
Crossref
Arlou Angeles, Simone Bauer, Leonie Ratz, Sabine Klauck & Holger Sültmann. (2018) Genome-Based Classification and Therapy of Prostate Cancer. Diagnostics 8:3, pages 62.
Crossref
Crossref
Jieying Liu, So Youn Kim, Sun Shin, Seung-Hyun Jung, Seon-Hee Yim, Ji Youl Lee, Sug-Hyung Lee & Yeun-Jun Chung. (2018) Overexpression of TFF3 is involved in prostate carcinogenesis via blocking mitochondria-mediated apoptosis. Experimental & Molecular Medicine 50:8, pages 1-11.
Crossref
Crossref
Cristian Arriaga-Canon, Inti Alberto De La Rosa-Velázquez, Rodrigo González-Barrios, Rogelio Montiel-Manríquez, Diego Oliva-Rico, Francisco Jiménez-Trejo, Carlo Cortés-González & Luis A. Herrera. (2018) The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer. Oncotarget 9:29, pages 20872-20890.
Crossref
Crossref
Caroline K. Søgaard, Siver A. Moestue, Morten B. Rye, Jana Kim, Anala Nepal, Nina-Beate Liabakk, Siri Bachke, Tone F. Bathen, Marit Otterlei & Deborah K. Hill. (2018) APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer. Oncotarget 9:14, pages 11752-11766.
Crossref
Crossref
Karl Pummer. (2017) Wie weit sind die molekularen Marker beim Prostatakarzinom?Où en sont les marqueurs moléculaires du cancer prostatique?. Journal für Urologie und Urogynäkologie/Schweiz 19:4, pages 103-108.
Crossref
Crossref
Karl Pummer. (2017) Wie weit sind die molekularen Marker beim Prostatakarzinom?How far advanced are molecular markers of prostate cancer?. Journal für Urologie und Urogynäkologie/Österreich 24:4, pages 111-116.
Crossref
Crossref
Emilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, Michael Fraser, Syed Haider, Alice Meng, Junyan Zheng, Cindy Q. Yao, Valerie Picard, Michele Orain, Helène Hovington, Jure Murgic, Alejandro Berlin, Louis Lacombe, Alain Bergeron, Yves Fradet, Bernard Têtu, Johan Lindberg, Lars Egevad, Henrik Grönberg, Helen Ross-Adams, Alastair D. Lamb, Silvia Halim, Mark J. Dunning, David E. Neal, Melania Pintilie, Theodorus van der Kwast, Robert G. Bristow & Paul C. Boutros. (2017) Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors. European Urology 72:1, pages 22-31.
Crossref
Crossref